Skin xerosis in hemodialyzed patient
Conditions
Interventions
Base treatment
Base treatment + moisturizer
Sponsors
The Kidney Disease Clinic of Nippon Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Chronic renal failure patients who regularly receive hemodialysis two or three times a week and are not likely to have a serious treatment change or acute symptoms during the study period. (2) Patients with skin xerosis (3) Patients with pruritus at time of signing the consent form (4) Patients who signed informed consent. (5) Patients aged 20 to 80 years at time of signing the consent form. (6) Patients of either sex.
Exclusion criteria
Exclusion criteria: (1) Patients who received heparinoid- or urea -containing drugs within two weeks before signing the consent form. (2) Patients with/ with the past of extensive complications of the skin (burn, psoriasis etc.). (3) Patients with allergy to heparinoid. (4) Patients with hemorrhagic blood disease (hemophilia, thrombocytopenia, purpura etc.). (5) Patients who are expected a few bleeding causes a serious result. (6) Patients who participated in other clinical study within 4 months before starting study. (7) Patients who are unsuitable to the study at the investigator's discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The water content of the stratum corneum | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy (Skin xerosis, pruritus, etc. ), Safety | — |
Countries
Japan
Contacts
Public ContactKazumasa Hashimoto
Nippon Medical School The Kidney Disease Clinic of NMS
Outcome results
None listed